George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
(Alliance News) - Scapa Group PLC on Tuesday said its first quarter performance is in line with board expectations, with growth in its Healthcare and Industrial units.
Shares in Scapa were up 3.5% at 171.40 pence in morning trade.
At its annual general meeting, Larry Pentz, chair of the bonding and adhesive-based products manufacturer, will announce 48% reported growth in Healthcare revenue and 4.5% in Industrial revenue. Total revenue growth for the quarter ended June 30 was 22% and 18% at constant currency.
On a continuing basis, Scapa revenue growth was 19% and on an organic basis, excluding its acquisitions of Systagenix and revenue from ConvaTec - which terminated its master supply agreement with Scapa in June.
"The integration and consolidation projects are proceeding according to plan and the company continues to seek additional opportunities to deliver long-term sustainable growth," Scapa said.
"The board considers Scapa to be well positioned to make further progress against its strategic objectives and remains confident in the group's outlook," the company added.
Healthcare is a growing market with an aging population. Industrial growth will accelerate with Scapa Group involved in solar panels and car manufacturing which will rebound with the electric revolution gathering pace and big brands realizing that, it's all good imho.
Scapa In Line With Expectations; Healthcare And Industrials Grow
Tue, 23rd Jul 2019 10:01
(Alliance News) - Scapa Group PLC on Tuesday said its first quarter performance is in line with board expectations, with growth in its Healthcare and Industrial units.
Shares in Scapa were up 3.5% at 171.40 pence in morning trade.
At its annual general meeting, Larry Pentz, chair of the bonding and adhesive-based products manufacturer, will announce 48% reported growth in Healthcare revenue and 4.5% in Industrial revenue. Total revenue growth for the quarter ended June 30 was 22% and 18% at constant currency.
On a continuing basis, Scapa revenue growth was 19% and on an organic basis, excluding its acquisitions of Systagenix and revenue from ConvaTec - which terminated its master supply agreement with Scapa in June.
"The integration and consolidation projects are proceeding according to plan and the company continues to seek additional opportunities to deliver long-term sustainable growth," Scapa said.
"The board considers Scapa to be well positioned to make further progress against its strategic objectives and remains confident in the group's outlook," the company added.